On the Frontlines of Retinal Diseases
Managing retinal diseases like wet age-related macular degeneration (AMD) and diabetic macular edema (DME) requires more than an understanding of the latest treatment options. From assessing disease activity and evaluating treatment response to addressing treatment burden and long-term adherence, clinicians face complex decisions at every stage of the patient journey.
That’s why our On the Frontlines of Retinal Diseases series is here to provide practical perspectives on the day-to-day realities of patient care.

Extended Dosing Strategies for Diabetic Retinopathy and DME
Eye on Ocular HealthExtended Dosing Strategies for Diabetic Retinopathy and DME

ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Eye on Ocular HealthILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME

A Vision for Change: Exploring Biosimilars in Retinal Disease Management
Eye on Ocular HealthA Vision for Change: Exploring Biosimilars in Retinal Disease Management
- advertisement








